• Uremic Metabolite Adsorption on Hydroxy-PEO Films: Implicati

  2026-04-22

  This study systematically quantifies the adsorption of uremic metabolites, including 4-ethylphenyl sulfate, onto hydroxy-terminated polyethylene oxide (PEO–OH) thin films at varying chain densities. The findings reveal that both the chemical structure of the metabolite and the physicochemical properties of the PEO–OH surface critically influence adsorption, directly informing biomaterial design for blood-contacting devices and advancing the understanding of renal dysfunction biomarkers.

• TAK-242 (Resatorvid): Precision TLR4 Inhibition in Neuroinfl

  2026-04-22

  This thought-leadership article illuminates the mechanistic and translational advantages of TAK-242 (Resatorvid), a selective TLR4 inhibitor, for researchers tackling neuroinflammation and cytokine-driven disease. It synthesizes actionable guidance, evidence-based protocol parameters, and strategic insights for advancing bench-to-bedside research—differentiating itself by bridging immunological mechanism with clinical foresight.

• Spatially Patterned Kidney Assembloids Advance Disease Model

  2026-04-21

  Huang et al. introduce human kidney progenitor assembloids (hKPAs) that recapitulate nephron self-assembly and spatial patterning, overcoming key limitations of previous organoid models. This approach enables high-fidelity modeling of kidney diseases, with implications for regenerative medicine and translational research.

• Carfilzomib Sensitizes ESCC to Iodine-125 via Multi-Modal Ce

  2026-04-21

  This study demonstrates that Carfilzomib (PR-171), an irreversible proteasome inhibitor, enhances the anti-tumor effects of Iodine-125 seed radiation in esophageal squamous cell carcinoma (ESCC) by intensifying endoplasmic reticulum stress and triggering apoptosis, paraptosis, and ferroptosis. The paper offers significant mechanistic insights for radiosensitization strategies in ESCC.

• Dextromethorphan hydrobromide: NMDA Antagonist Protocols

  2026-04-20

  Dextromethorphan hydrobromide is a high-purity NMDA receptor antagonist suitable for controlled in vitro and in vivo assays addressing neuroprotection and excitotoxicity inhibition. It should not be used in diagnostic or clinical workflows, and strict adherence to solubility and storage guidelines is essential for reproducible research results.

• Chlorpromazine in Translational Antipsychotic Research: Mech

  2026-04-20

  This thought-leadership article frames the strategic role of Chlorpromazine (SKU C6410) as a mechanistically validated dopamine D2 receptor antagonist in antipsychotic research. By bridging molecular pharmacology with translational research imperatives, it provides experimental guidance, evaluates the competitive landscape, and reflects on the clinical and future-facing implications, uniquely referencing recent insights from nanoparticle-liver interaction studies to illustrate evolving standards for mechanistic rigor and targeted delivery in CNS drug development.

• Protease Inhibitor Cocktail: Precision in Protein Degradatio

  2026-04-19

  The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) from APExBIO delivers robust, broad-spectrum protection against proteolysis during extraction and lysis. This article distills evidence-backed workflows, troubleshooting, and practical insights for maximizing reproducibility in advanced protein assays.

• Sisomicin: Aminoglycoside Antibiotic Workflows for Infection

  2026-04-18

  Sisomicin empowers researchers with robust, reproducible antibacterial assays against both Gram-negative and Gram-positive pathogens. This article details stepwise protocols, troubleshooting tactics, and advanced applications that maximize data integrity and translational relevance in infection research.

• Promethazine HCl: Applied Workflows for Immunology & Inflamm

  2026-04-17

  Promethazine HCl is redefining host-pathway research by enabling precise dissection of histaminergic signaling and immune modulation. Recent studies show it enhances macrophage antibacterial activity via ROS and autophagy—unlocking new assay strategies against intracellular pathogens and antibiotic resistance.

• Cy5-UTP: Precision RNA Labeling for Advanced Molecular Workf

  2026-04-16

  Cy5-UTP (Cyanine 5-uridine triphosphate) enables direct, high-sensitivity RNA probe synthesis for fluorescence-based assays, including FISH and multicolor expression profiling. This guide delivers actionable, protocol-level strategies, troubleshooting insights, and practical application tips to maximize Cy5-UTP’s impact in experimental RNA biology.

• Lenalidomide (CC-5013): Unlocking Immune Synergy in Myeloma

  2026-04-15

  This article explores the evolving landscape of lenalidomide (CC-5013) as both an immune system activation agent and angiogenesis inhibitor, with a focus on its mechanistic underpinnings, translational research protocols, and the latest evidence for combinational strategies in multiple myeloma. Building on recent epigenetic insights, it provides actionable guidance for researchers seeking to maximize lenalidomide’s impact in hematologic malignancy models.

• Polymeric Nanozymes Target Intramacrophage Bacteria to Enhan

  2026-04-14

  This study reports a self-activatable polymeric nanozyme engineered to eradicate Fusobacterium nucleatum inside tumor-associated macrophages, reversing immunosuppression and improving CD47 blockade immunotherapy for colorectal cancer. The findings underscore a new paradigm for modulating the tumor immune microenvironment through precision targeting of intracellular bacterial reservoirs.

• NADPH Oxidase-ROS Activate L-type Ca2+ Channels in Neonatal

  2026-04-13

  This study elucidates that NADPH oxidase-derived reactive oxygen species (ROS) induce arterial contraction in early postnatal rats predominantly via activation of L-type voltage-gated calcium channels (LTCC), independent of canonical protein kinases like Rho-kinase, PKC, or Src-kinase. These findings clarify the age-dependent vascular roles of ROS and inform methodological choices in kinase signaling pathway research.

• S-Adenosylhomocysteine: Mechanism, Evidence, and Research Us

  2026-04-12

  S-Adenosylhomocysteine (SAH) is an essential metabolic intermediate and feedback inhibitor of methyltransferases, tightly regulating cellular methylation potential. It is pivotal in cystathionine β-synthase (CBS) deficiency research, methyltransferase inhibition, and modulation of the SAM/SAH ratio. APExBIO's SAH (B6123) offers high solubility and reproducibility for in vitro and in vivo studies.

• Dual Caspase-Dependent Antagonism Between SVA Proteins and D

  2026-04-12

  This study reveals how Senecavirus A (SVA) manipulates host apoptosis machinery via its 3A and 2B proteins, counteracting the antiviral restriction factor DDX23 through distinct caspase pathways. The findings provide molecular insight into SVA-host interactions, highlighting new targets for antiviral strategies and deepening our understanding of apoptosis modulation in viral infection contexts.

16189 records 1/1080 page Next 12345 下5页 Last page